IPP Bureau
Indian govt. places order for five crore doses of Corbevax
By IPP Bureau - February 05, 2022
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Lupin Q3FY22 PAT at Rs 545.52 cr.
By IPP Bureau - February 04, 2022
Lupin has reported consolidated financial results for the period ended December 31, 2021
Pfizer Q3FY22 PAT at Rs 143.91 crore
By IPP Bureau - February 04, 2022
The company has reported standalone financial results for the period ended December 31, 2021.
Sun Pharma demonstrates strong performance on all fronts: ICICI Direct
By IPP Bureau - February 04, 2022
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
Thermo Scientific launches Nicolet RaptIR FTIR microscope
By IPP Bureau - February 04, 2022
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Germfree launches novel mobile cleanroom technology for advanced therapies
By IPP Bureau - February 04, 2022
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Sir HN Reliance Foundation Hospital partners with Karkinos Healthcare for community cancer screening
By IPP Bureau - February 04, 2022
The target demographic will be those between the ages of 30 and 65 years
AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
By IPP Bureau - February 04, 2022
It has signed an MoU with Plan India to expand its reach to Karnataka
BGS Gleneagles Global Hospital unveils #SelfE campaign to fight breast cancer early
By IPP Bureau - February 04, 2022
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
Sputnik V vaccine granted full approval in Russia
By IPP Bureau - February 04, 2022
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Mylab launches CoviSwift for Covid-19 Point of Care testing
By IPP Bureau - February 03, 2022
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s impresses on sustainability and gender equality again
By IPP Bureau - February 03, 2022
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
Pristyn Care doubles it surgical centres to 800 in 2021
By IPP Bureau - February 03, 2022
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr
By IPP Bureau - February 03, 2022
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Granules receives ANDA approval for anti-depressant medication
By IPP Bureau - February 03, 2022
It has a total of 50 ANDA approvals from USFDA
